SAMLYN CAPITAL, LLC - Q1 2016 holdings

$4.66 Billion is the total value of SAMLYN CAPITAL, LLC's 170 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 0.0% .

 Value Shares↓ Weighting
PHH  PHH CORP$34,744,000
-22.6%
2,770,6560.0%0.75%
-19.8%
STBZ  STATE BK FINL CORP$21,736,000
-6.0%
1,100,0000.0%0.47%
-2.5%
KW  KENNEDY-WILSON HLDGS INC$13,653,000
-9.1%
623,4250.0%0.29%
-5.8%
OREX  OREXIGEN THERAPEUTICS INC$3,466,000
-67.3%
6,160,4170.0%0.07%
-66.2%
WMIH  WMIH CORP$125,000
-9.4%
53,4200.0%0.00%0.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LPL FINL HLDGS INC33Q2 20247.7%
AMAZON COM INC33Q2 20244.1%
BIOGEN INC30Q3 20234.7%
VOYA FINL INC25Q4 20235.8%
BURLINGTON STORES INC25Q1 20243.7%
WAYFAIR INC24Q2 20231.5%
CONSTELLATION BRANDS INC23Q4 20184.6%
HDFC BANK LTD23Q3 20203.5%
INTRA-CELLULAR THERAPIES INC23Q3 20220.8%
ICICI BK LTD22Q1 20234.0%

View SAMLYN CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SAMLYN CAPITAL, LLC Q1 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Applied Minerals, Inc.March 11, 202485,144,32817.6%
Inozyme Pharma, Inc.February 14, 20243,372,5585.5%
Merus N.V.February 14, 20243,412,4105.9%
Vinci Partners Investments Ltd.February 14, 20242,629,5716.5%
Eliem Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Glass Houses Acquisition Corp.Sold outFebruary 14, 202300.0%
Perella Weinberg PartnersSold outFebruary 14, 202300.0%
Satsuma Pharmaceuticals, Inc.Sold outFebruary 14, 202300.0%
Falcon Minerals CorpSold outFebruary 14, 202200.0%
Sculptor Capital Management, Inc.Sold outFebruary 14, 202200.0%

View SAMLYN CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-09-20
N-PX2024-08-30
13F-HR2024-08-14
SC 13G/A2024-08-01
13F-HR2024-05-15
SC 13G/A2024-05-13
SC 13D/A2024-03-11
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View SAMLYN CAPITAL, LLC's complete filings history.

Compare quarters

Export SAMLYN CAPITAL, LLC's holdings